Results 171 to 180 of about 6,513 (203)

The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma

open access: yesInternational Journal of Molecular Sciences, 2021
SET domain bifurcated 1 (SETDB1) is a histone H3 lysine 9 (H3K9) methyltransferase that exerts important effects on epigenetic gene regulation. SETDB1 complexes (SETDB1-KRAB-KAP1, SETDB1-DNMT3A, SETDB1-PML, SETDB1-ATF7IP-MBD1) play crucial roles in the ...
Wen-Bin Ou
exaly   +2 more sources

Hypoxia Stabilizes SETDB1 to Maintain Genome Stability.

open access: yesNucleic Acids Research, 2023
Abstract Von Hippel–Lindau (VHL) is a tumor suppressor that functions as the substrate recognition subunit of the CRL2VHL E3 complex. While substrates of VHL have been identified, its tumor suppressive role remains to be fully understood.
Jung-Ae Kim, Seon-Young Kim, Ga Seul Lee
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

SETDB1, a new target for immunotherapy

Nature Reviews Cancer, 2021
Griffin, Wu, Iracheta-Vellve et al. identified SETDB1 as an immunosuppressive epigenetic modulator in cancer.
openaire   +2 more sources

Emerging role of SETDB1 as a therapeutic target

Expert Opinion on Therapeutic Targets, 2017
Epigenetic changes lead to aberrant gene expression in cancer. SETDB1, a histone lysine methyltransferase plays an important role in methylation and gene silencing. Aberrant histone methylation at H3K9 by SETDB1 promotes silencing of tumor suppressor genes and thus contributes to carcinogenesis.
Archana Venkataramana, Karanth   +7 more
openaire   +2 more sources

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

Nature, 2021
Epigenetic dysregulation is a defining feature of tumorigenesis that is implicated in immune escape1,2. Here, to identify factors that modulate the immune sensitivity of cancer cells, we performed in vivo CRISPR-Cas9 screens targeting 936 chromatin regulators in mouse tumour models treated with immune checkpoint blockade.
Gabriel K. Griffin   +28 more
openaire   +4 more sources

Alcoholic Setdb1 Suppression Promotes Hepatosteatosis in Mice by Strengthening Plin2

Metabolism: Clinical and Experimental, 2023
Hepatosteatosis is one of the early features of alcoholic liver disease (ALD) and pharmaceutical or genetic interfering of the development of hepatosteatosis will efficiently alleviate the progression of ALD. Currently, the role of histone methyltransferase Setdb1 in ALD is not yet well understood.Lieber-De Carli diet mice model and NIAAA mice model ...
Yi, Zhang   +12 more
exaly   +3 more sources

Histone methyltransferase Setdb1 is indispensable for Meckel's cartilage development

Biochemical and Biophysical Research Communications, 2017
The histone methyltransferase Setdb1 represses gene expression by catalyzing lysine 9 of histone H3 trimethylation. Given that the conventional knockout of Setdb1 is embryo-lethal at the implantation stage, its role in craniofacial development is poorly understood.
Kohei, Yahiro   +2 more
openaire   +2 more sources

Analysis of the subcellular localization of the human histone methyltransferase SETDB1

Biochemical and Biophysical Research Communications, 2015
SET domain, bifurcated 1 (SETDB1) is a histone methyltransferase that methylates lysine 9 on histone H3. Although it is important to know the localization of proteins to elucidate their physiological function, little is known of the subcellular localization of human SETDB1.
Keisuke, Tachibana   +13 more
openaire   +2 more sources

Elucidating the distinct molecular mechanisms of Setdb1

2020
Setdb1, a histone 3 lysine 9 (H3K9) methyltransferase, is a critical epigenetic regulator during various developmental progresses. While distinct functions have been described in diverse tissues and species, the molecular mechanism by which it can carry out such wide range of tasks is poorly understood.
openaire   +2 more sources

Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy

Current Cancer Drug Targets
Epigenetic alterations are implicated in the early stages of tumorigenesis and are widely recognized as a ubiquitous phenomenon in cancer development. Aberrant epigenetic modifications can alter the expression of target genes, induce heterochromatin formation, and gradually drive normal cells towards immortalized tumor cells with significant ...
Cheng, Peng   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy